121 related articles for article (PubMed ID: 2601582)
21. Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
López FJ; Dominguez JR; Sánchez-Franco F; Negro-Vilar A
Endocrinology; 1989 Jan; 124(1):527-35. PubMed ID: 2909379
[TBL] [Abstract][Full Text] [Related]
22. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
[TBL] [Abstract][Full Text] [Related]
23. Plasma luteinizing hormone and prolactin levels and hypothalamic catecholamine synthesis in steroid-treated ovariectomized rats.
Jimenez AE; Voogt JL; Carr LA
Neuroendocrinology; 1977; 23(6):341-51. PubMed ID: 593526
[TBL] [Abstract][Full Text] [Related]
24. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
Ho KY; Smythe GA; Lazarus L
Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
[TBL] [Abstract][Full Text] [Related]
25. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
Leadem CA; Kalra SP
Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
[TBL] [Abstract][Full Text] [Related]
26. Norepinephrine content in the paraventicular nucleus of the hypothalamus as a function of photoperiod and dopaminergic tone.
Woods KA; Buechi KA; Illig AM; Badura LL
Endocrine; 1998 Feb; 8(1):79-83. PubMed ID: 9666349
[TBL] [Abstract][Full Text] [Related]
27. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of the effects of lisuride and pimozide on the preovulatory surge of FSH, LH and prolactin in rat.
Kun I; Simionescu L; Oprescu M; Zamfir-Grigorescu D
Endocrinologie; 1984; 22(3):177-82. PubMed ID: 6436960
[TBL] [Abstract][Full Text] [Related]
29. Posterior pituitary lobectomy: differential elevation of plasma prolactin and luteinizing hormone in estrous and lactating rats.
Ben-Jonathan N; Peters LL
Endocrinology; 1982 Jun; 110(6):1861-5. PubMed ID: 7075542
[TBL] [Abstract][Full Text] [Related]
30. Plasma prolactin and luteinizing hormone profiles during the estrous cycle of the female rat: effects of surgically induced persistent estrus.
Ronnekleiv OK; Kelly MJ
Neuroendocrinology; 1988 Feb; 47(2):133-41. PubMed ID: 3344065
[TBL] [Abstract][Full Text] [Related]
31. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N
Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
[TBL] [Abstract][Full Text] [Related]
32. Blockade of dopamine (DA) receptors with pimozide and pituitary hormone release in response to intraventricular injection of gamma-aminobutyric acid (GABA) in conscious ovariectomized rats.
Vijayan E; McCann SM
Brain Res; 1979 Feb; 162(1):69-76. PubMed ID: 761087
[No Abstract] [Full Text] [Related]
33. Role of dopamine in the inhibitory control of growth hormone and prolactin release by gastrin-releasing peptide.
Kentroti S; McCann SM
Brain Res Bull; 1996; 39(4):201-4. PubMed ID: 8963684
[TBL] [Abstract][Full Text] [Related]
34. Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women.
la Marca A; Torricelli M; Morgante G; Lanzetta D; De Leo V
Horm Res; 1999; 51(2):85-90. PubMed ID: 10352398
[TBL] [Abstract][Full Text] [Related]
35. Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat.
Briski KP; Quigley K; Meites J
Life Sci; 1984 Jun; 34(25):2485-93. PubMed ID: 6374352
[TBL] [Abstract][Full Text] [Related]
36. Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
Gala RR; Haisenleder DJ
Neuroendocrinology; 1986; 43(2):115-23. PubMed ID: 3724981
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopamine blockade on gonadotropins and testosterone in men.
Siris SG; Siris ES; van Kammen DP; Docherty JP; Alexander PE; Bunney WE
Am J Psychiatry; 1980 Feb; 137(2):211-4. PubMed ID: 7352577
[TBL] [Abstract][Full Text] [Related]
38. Histaminergic regulation of prolactin secretion: involvement of tuberoinfundibular dopaminergic neurons.
Knigge U; Matzen S; Warberg J
Neuroendocrinology; 1988 Aug; 48(2):167-73. PubMed ID: 2975768
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of gonadotropin secretion induced by cholecystokinin implants in the medial preoptic area by the dopamine receptor blocker, pimozide, in the rat.
Hashimoto R; Kimura F
Neuroendocrinology; 1986; 42(1):32-7. PubMed ID: 3079892
[TBL] [Abstract][Full Text] [Related]
40. Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress.
Briski KP; Sylvester PW
Psychoneuroendocrinology; 1992; 17(2-3):125-33. PubMed ID: 1332097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
